Trial Profile
A Randomized, Double-Blind, Double-Dummy, Efficacy, Safety and Tolerability Study Levodopa - Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects Receiving Optimized Treatments with Parkinson Medicinal Products who Continue to Experience Persistent Motor Fluctuations
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 13 Oct 2016
Price :
$35
*
At a glance
- Drugs Levodopa/carbidopa (Primary) ; Levodopa/carbidopa
- Indications Parkinson's disease
- Focus Registrational; Therapeutic Use
- Sponsors AbbVie
- 28 Jan 2016 Pooled exploratory post-hoc analysis of 3 trials including this trial and 2 other studies [see CTP 700027941 and 70033178] were published in the Movement Disorders.
- 23 Mar 2013 Results presented at the 65th Annual Meeting of the American Academy of Neurology.
- 12 Oct 2012 New source identified and integrated (European Clinical Trials Database; EudraCT2006-000577-29).